G1 Therapeutics Operating Income 2016-2024 | GTHX
G1 Therapeutics operating income from 2016 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| G1 Therapeutics Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-40 |
| 2022 | $-136 |
| 2021 | $-142 |
| 2020 | $-96 |
| 2019 | $-129 |
| 2018 | $-89 |
| 2017 | $-61 |
| 2016 | $-30 |
| 2015 | $-15 |
| G1 Therapeutics Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-4 |
| 2024-03-31 | $-9 |
| 2023-12-31 | $-9 |
| 2023-09-30 | $-16 |
| 2023-06-30 | $12 |
| 2023-03-31 | $-26 |
| 2022-12-31 | $-31 |
| 2022-09-30 | $-22 |
| 2022-06-30 | $-37 |
| 2022-03-31 | $-47 |
| 2021-12-31 | $-38 |
| 2021-09-30 | $-41 |
| 2021-06-30 | $-38 |
| 2021-03-31 | $-26 |
| 2020-12-31 | $-24 |
| 2020-09-30 | $-10 |
| 2020-06-30 | $-31 |
| 2020-03-31 | $-32 |
| 2019-12-31 | $-37 |
| 2019-09-30 | $-34 |
| 2019-06-30 | $-33 |
| 2019-03-31 | $-26 |
| 2018-12-31 | $-26 |
| 2018-09-30 | $-21 |
| 2018-06-30 | $-22 |
| 2018-03-31 | $-21 |
| 2017-12-31 | $-17 |
| 2017-09-30 | $-16 |
| 2017-06-30 | $-15 |
| 2017-03-31 | $-12 |
| 2016-12-31 | |
| 2016-09-30 | $-7 |
| 2016-06-30 | $-7 |
| 2015-12-31 | |
